300
Participants
Start Date
August 31, 2001
Primary Completion Date
September 30, 2003
Study Completion Date
September 30, 2003
Seloken ZOK/Toprol-XL
50 mg
Seloken ZOK/Toprol-XL
200 mg
Placebo
Birmingham
Mobile
Little Rock
Los Angeles
Northridge
Redondo Beach
Riverside
Research Site, Farmington
Clearwater
Melbourne
Vero Beach
Augusta
Indianapolis
Jeffersonville
Edgewood
New Orleans
Shreveport
Auburn
Baltimore
Salisbury
Boston
Saint Charles
St Louis
Omaha
Albuquerque
Buffalo
East Syracuse
New York
Rochester
The Bronx
Williamsville
Burlington
Columbus
Oklahoma City
Flourtown
Philadelphia
Pittsburgh
Lincoln
Wakefield
Tyler
Salt Lake City
Chesapeake
Roanoke
Green Bay
Lead Sponsor
AstraZeneca
INDUSTRY